Please assess the completion status of the following clinical trial:

Trial Title: Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* subject is undergoing resection of pancreas for pancreatic ductal adenocarcinoma (PDAC)~* subject must have adequate renal function~* ECOG performance status of 0-2~* women of child-bearing age and men must agree to use contraception prior to and during the study~Exclusion Criteria:~* subjects receiving any other investigational agents~* significant history of uncontrolled cardiac disease or central nervous system (CNS) disease~* pregnant or breastfeeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PTP-01 (Type: EXPERIMENTAL): single IV bolus dose 24 hours prior to surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).